NCT04326257 2026-01-08Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior ImmunotherapyUniversity of PittsburghPhase 2 Completed20 enrolled 13 charts
NCT03638141 2025-08-17CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and TremelimumabSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed21 enrolled 12 charts